- Home
- CDNA vs LENZ Comparison
CDNA vs LENZ Comparison
Compare CDNA & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDNA
- LENZ
- Stock Information
- Founded
- CDNA 1998
- LENZ 2019
- Country
- CDNA United States
- LENZ United States
- Employees
- CDNA N/A
- LENZ N/A
- Industry
- CDNA Medical Specialities
- LENZ Medicinal Chemicals and Botanical Products
- Sector
- CDNA Health Care
- LENZ Health Care
- Exchange
- CDNA Nasdaq
- LENZ Nasdaq
- Market Cap
- CDNA 712.2M
- LENZ 852.0M
- IPO Year
- CDNA 2014
- LENZ 2021
- Fundamental
- Price
- CDNA $18.03
- LENZ $31.63
- Analyst Decision
- CDNA Buy
- LENZ Strong Buy
- Analyst Count
- CDNA 7
- LENZ 4
- Target Price
- CDNA $26.00
- LENZ $56.25
- AVG Volume (30 Days)
- CDNA 1.2M
- LENZ 1.3M
- Earning Date
- CDNA 11-04-2025
- LENZ 11-05-2025
- Dividend Yield
- CDNA N/A
- LENZ N/A
- EPS Growth
- CDNA N/A
- LENZ N/A
- EPS
- CDNA 1.22
- LENZ N/A
- Revenue
- CDNA $357,998,000.00
- LENZ $17,500,000.00
- Revenue This Year
- CDNA $12.73
- LENZ N/A
- Revenue Next Year
- CDNA $11.90
- LENZ $285.82
- P/E Ratio
- CDNA $14.75
- LENZ N/A
- Revenue Growth
- CDNA 14.46
- LENZ N/A
- 52 Week Low
- CDNA $10.96
- LENZ $16.54
- 52 Week High
- CDNA $26.37
- LENZ $50.40
- Technical
- Relative Strength Index (RSI)
- CDNA 67.03
- LENZ 55.37
- Support Level
- CDNA $15.60
- LENZ $27.44
- Resistance Level
- CDNA $17.09
- LENZ $26.81
- Average True Range (ATR)
- CDNA 1.02
- LENZ 2.41
- MACD
- CDNA 0.15
- LENZ 1.12
- Stochastic Oscillator
- CDNA 95.64
- LENZ 99.43
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
About LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.